0 CHECKOUT

Tuberculosis - Pipeline Review, H1 2015

  • ID: 3345026
  • June 2015
  • 359 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Abera Bioscience AB
  • CureVac GmbH
  • GangaGen Inc.
  • Immunovaccine, Inc.
  • Novartis AG
  • SEEK Group
  • MORE

Tuberculosis - Pipeline Review, H1 2015

Summary

the, ‘Tuberculosis - Pipeline Review, H1 2015’, provides an overview of the Tuberculosis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Tuberculosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tuberculosis and special features on late-stage and discontinued projects.

the report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from the proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by the team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abera Bioscience AB
  • CureVac GmbH
  • GangaGen Inc.
  • Immunovaccine, Inc.
  • Novartis AG
  • SEEK Group
  • MORE

Introduction
Tuberculosis Overview
Therapeutics Development
Tuberculosis - Therapeutics under Development by Companies
Tuberculosis - Therapeutics under Investigation by Universities/Institutes
Tuberculosis - Pipeline Products Glance
Tuberculosis - Products under Development by Companies
Tuberculosis - Products under Investigation by Universities/Institutes
Tuberculosis - Companies Involved in Therapeutics Development
Tuberculosis - Therapeutics Assessment
Drug Profiles
Tuberculosis - Recent Pipeline Updates
Tuberculosis - Dormant Projects
Tuberculosis - Discontinued Products
Tuberculosis - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Tuberculosis, H1 2015
Number of Products under Development for Tuberculosis - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Development by Companies, H1 2015 (Contd..3)
Number of Products under Development by Companies, H1 2015 (Contd..4)
Number of Products under Investigation by Universities/Institutes, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..2)
Number of Products under Investigation by Universities/Institutes, H1 2015 (Contd..3)
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Development by Companies, H1 2015 (Contd..4)
Products under Development by Companies, H1 2015 (Contd..5)
Products under Development by Companies, H1 2015 (Contd..6)
Products under Investigation by Universities/Institutes, H1 2015
Products under Investigation by Universities/Institutes, H1 2015 (Contd..1)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..2)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..3)
Products under Investigation by Universities/Institutes, H1 2015 (Contd..4)
Tuberculosis - Pipeline by Abera Bioscience AB, H1 2015
Tuberculosis - Pipeline by Achillion Pharmaceuticals, Inc., H1 2015
Tuberculosis - Pipeline by Akthelia pharmaceuticals ehf, H1 2015
Tuberculosis - Pipeline by Anacor Pharmaceuticals, Inc., H1 2015
Tuberculosis - Pipeline by Archivel Farma S.L., H1 2015
Tuberculosis - Pipeline by AstraZeneca Plc, H1 2015
Tuberculosis - Pipeline by BioDiem Ltd, H1 2015
Tuberculosis - Pipeline by Biomar Microbial Technologies, H1 2015
Tuberculosis - Pipeline by Bioversys AG, H1 2015
Tuberculosis - Pipeline by Cellceutix Corporation, H1 2015
Tuberculosis - Pipeline by Chongqing Zhifei Biological Products Co., Ltd., H1 2015
Tuberculosis - Pipeline by CureVac GmbH, H1 2015
Tuberculosis - Pipeline by Dafra Pharma International Ltd., H1 2015
Tuberculosis - Pipeline by Daiichi Sankyo Company, Limited, H1 2015
Tuberculosis - Pipeline by Eisai Co., Ltd., H1 2015
Tuberculosis - Pipeline by Eli Lilly and Company, H1 2015
Tuberculosis - Pipeline by Ensoltek Co., Ltd., H1 2015
Tuberculosis - Pipeline by EpiVax, Inc., H1 2015
Tuberculosis - Pipeline by FIT Biotech Oy, H1 2015
Tuberculosis - Pipeline by GangaGen Inc., H1 2015
Tuberculosis - Pipeline by GlaxoSmithKline Plc, H1 2015
Tuberculosis - Pipeline by Globeimmune, Inc., H1 2015
Tuberculosis - Pipeline by Imaxio SA, H1 2015
Tuberculosis - Pipeline by Immunitor, Inc., H1 2015
Tuberculosis - Pipeline by ImmunoBiology Limited, H1 2015
Tuberculosis - Pipeline by Immunovaccine, Inc., H1 2015
Tuberculosis - Pipeline by Inovio Pharmaceuticals, Inc., H1 2015
Tuberculosis - Pipeline by iThemba Pharmaceuticals (Pty) Ltd., H1 2015
Tuberculosis - Pipeline by Johnson & Johnson, H1 2015
Tuberculosis - Pipeline by Lipotek Pty Ltd., H1 2015
Tuberculosis - Pipeline by Microbion Corporation, H1 2015
Tuberculosis - Pipeline by Microbiotix, Inc., H1 2015
Tuberculosis - Pipeline by NEARMEDIC PLUS, Ltd, H1 2015
Tuberculosis - Pipeline by Novartis AG, H1 2015
Tuberculosis - Pipeline by Okklo Life Sciences BV, H1 2015
Tuberculosis - Pipeline by Orchid Chemicals & Pharmaceuticals Ltd, H1 2015
Tuberculosis - Pipeline by Otsuka Holdings Co., Ltd., H1 2015
Tuberculosis - Pipeline by Polymun Scientific Immunbiologische Forschung GmbH, H1 2015
Tuberculosis - Pipeline by Prokarium Limited, H1 2015
Tuberculosis - Pipeline by Sanofi, H1 2015
Tuberculosis - Pipeline by Sanofi Pasteur SA, H1 2015
Tuberculosis - Pipeline by Sarepta Therapeutics, Inc., H1 2015
Tuberculosis - Pipeline by SEEK Group, H1 2015
Tuberculosis - Pipeline by Sequella, Inc., H1 2015
Tuberculosis - Pipeline by Snowdon Inc., H1 2015
Tuberculosis - Pipeline by Sphaera Pharma Pvt. Ltd., H1 2015
Tuberculosis - Pipeline by Syntrix Biosystems, Inc., H1 2015
Tuberculosis - Pipeline by Takeda Pharmaceutical Company Limited, H1 2015
Tuberculosis - Pipeline by TetraLogic Pharmaceuticals, H1 2015
Tuberculosis - Pipeline by Theravectys S.A., H1 2015
Tuberculosis - Pipeline by Transgene SA, H1 2015
Tuberculosis - Pipeline by TVAX Biomedical, Inc., H1 2015
Tuberculosis - Pipeline by Vaccibody AS, H1 2015
Tuberculosis - Pipeline by Vakzine Projekt Management GmbH, H1 2015
Tuberculosis - Pipeline by Vaxil Bio Therapeutics Ltd., H1 2015
Tuberculosis - Pipeline by Vertex Pharmaceuticals Incorporated, H1 2015
Tuberculosis - Pipeline by Vichem Chemie Research Ltd., H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Tuberculosis Therapeutics - Recent Pipeline Updates, H1 2015
Tuberculosis - Dormant Projects, H1 2015
Tuberculosis - Dormant Projects (Contd..1), H1 2015
Tuberculosis - Dormant Projects (Contd..2), H1 2015
Tuberculosis - Dormant Projects (Contd..3), H1 2015
Tuberculosis - Dormant Projects (Contd..4), H1 2015
Tuberculosis - Dormant Projects (Contd..5), H1 2015
Tuberculosis - Discontinued Products, H1 2015

List of Figures
Number of Products under Development for Tuberculosis, H1 2015
Number of Products under Development for Tuberculosis - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

Abera Bioscience AB
Achillion Pharmaceuticals, Inc.
Akthelia pharmaceuticals ehf
Anacor Pharmaceuticals, Inc.
Archivel Farma S.L.
AstraZeneca Plc
BioDiem Ltd
Biomar Microbial Technologies
Bioversys AG
Cellceutix Corporation
Chongqing Zhifei Biological Products Co., Ltd.
CureVac GmbH
Dafra Pharma International Ltd.
Daiichi Sankyo Company, Limited
Eisai Co., Ltd.
Eli Lilly and Company
Ensoltek Co., Ltd.
EpiVax, Inc.
FIT Biotech Oy
GangaGen Inc.
GlaxoSmithKline Plc
Globeimmune, Inc.
Imaxio SA
Immunitor, Inc.
ImmunoBiology Limited
Immunovaccine, Inc.
Inovio Pharmaceuticals, Inc.
iThemba Pharmaceuticals (Pty) Ltd.
Johnson & Johnson
Lipotek Pty Ltd.
Microbion Corporation
Microbiotix, Inc.
NEARMEDIC PLUS, Ltd
Novartis AG
Okklo Life Sciences BV
Orchid Chemicals & Pharmaceuticals Ltd
Otsuka Holdings Co., Ltd.
Polymun Scientific Immunbiologische Forschung GmbH
Prokarium Limited
Sanofi
Sanofi Pasteur SA
Sarepta Therapeutics, Inc.
SEEK Group
Sequella, Inc.
Snowdon Inc.
Sphaera Pharma Pvt. Ltd.
Syntrix Biosystems, Inc.
Takeda Pharmaceutical Company Limited
TetraLogic Pharmaceuticals
Theravectys S.A.
Transgene SA
TVAX Biomedical, Inc.
Vaccibody AS
Vakzine Projekt Management GmbH
Vaxil Bio Therapeutics Ltd.
Vertex Pharmaceuticals Incorporated
Vichem Chemie Research Ltd.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Maquet Getinge Group
  • Emergent BioSolutions, Inc.
  • Aicuris GmbH & Co.KG
  • Merck & Co., Inc.